Post-earnings recap
Reported
Tue, Jun 2, 2015
Est. EPS
—
Est. revenue
—
Implied move
—
EPS beat rate
88%
Medtronic's better-than-expected EPS indicates strong performance in managing costs and profitability. The stock's slight increase of 0.23% reflects investor approval of the earnings results, even though no revenue figures were disclosed. The lack of guidance may leave some investors cautious about future performance.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $1.16 | N/A | +4.13% |
Management expressed satisfaction with the EPS results, highlighting their commitment to innovation. However, they did not provide specific guidance for future quarters.
We are pleased with our EPS performance this quarter.
Our focus remains on innovation and improving patient outcomes.
—
Est. EPS
—
Est. Rev
—
Impl. Move
—